Predictors of anti-VEGF efficacy in chronic central serous chorioretinopathy based on intraocular cytokine levels and pigment epithelium detachment subtypes.
Jianbo MaoCaiyun ZhangShian ZhangChenyi LiuNuo ChenJiwei TaoXiangjun SheZicheng ZhengZhe LvLijun ShenPublished in: Acta ophthalmologica (2022)
Patients with FIPED in chronic CSC had elevated intraocular VEGF levels and responded favourably to conbercept. Anti-VEGF treatment may be an option for FIPED CSC patients with or without secondary CNV.